Cardinal Health stock holds near its yearly high

Published on 09/22/2026 at 10:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health stock closed at USD 224.95 on September 18, 2026, 18.5 percent below the USD 266.56 consensus target. Fiscal 2026 revenue rose 14 percent.

Fotorealistisches Pharma-Distributionslager mit Gabelstapler und Mitarbeitern in Dublin Ohio — Cardinal Health Inc. betreibt ein modernes Pharma-Distributionslager in Dublin, Ohio – ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health stock (ISIN US14149Y1082) closed at USD 224.95 on the NYSE on September 18, 2026, leaving the shares 18.5 percent below the reported consensus target of USD 266.56. The latest company figures show fiscal 2026 revenue of USD 254.2 billion, up 14 percent year over year.

Fiscal 2026 delivered double digit growth

According to StockTitan on September 21, 2026, Cardinal Health reported fiscal 2026 revenue of USD 254.2 billion, a 14 percent increase from the prior year. GAAP operating earnings rose 15 percent to USD 2.6 billion, while non-GAAP operating earnings increased 30 percent to USD 3.6 billion.

The cash-flow figure was also notable. Operating cash flow reached USD 5.2 billion in fiscal 2026, up 116 percent year over year, according to StockTitan. The combination of 14 percent revenue growth and 30 percent non-GAAP operating-earnings growth points to stronger operating leverage than the top line alone suggests.

Consensus remains above the share price

MarketBeat's September 21, 2026 overview cited a consensus rating of Moderate Buy based on 16 buy ratings and 3 hold ratings. The same overview placed the average price target at USD 266.56 and trailing earnings per share at USD 7.23, as reported in Ad-hoc News.

The comparison is substantial in absolute terms: the USD 266.56 consensus target stood USD 41.61 above the September 18 close of USD 224.95. A separate September 22, 2026 market commentary cited a median analyst target near USD 245.00, showing that estimates differ materially even while remaining above the latest quoted close.

Next earnings date is October 29

Zacks reported on September 21, 2026 that Cardinal Health was scheduled to report earnings on October 29, 2026. Its Most Accurate Estimate was USD 2.96 per share versus a consensus estimate of USD 2.92, producing an Earnings ESP of 1.29 percent.

The upcoming report therefore has two measurable reference points: fiscal 2026 operating performance and the current quarterly estimate. The stock's valuation discussion will depend on whether the October figures support the 30 percent fiscal-year increase in non-GAAP operating earnings.

Cardinal Health stock stays near yearly high

Cardinal Health stock closed at USD 224.95 on the NYSE on September 18, 2026. The close remained near the yearly high cited in current market coverage, while the USD 266.56 consensus target marked an 18.5 percent gap above the latest completed-session price.